Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Gilead Sciences Ltd
Flowers Building, Granta Park, Abington, Cambridge, Cambridge, CB21 6GT, UK
Telephone: +44 (0)1223 897 300
Fax: +44 (0)1223 897 291
Medical Information Direct Line: +44 (0)1223 897 555
Medical Information e-mail: ukmedinfo@gilead.com
Customer Care direct line: +44 (0)1223 897 400
Medical Information Fax: +44 (0)1223 897 281

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 06/01/2012
PIL Viread 245 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 30/08/2011 and displayed until 06/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 18/08/2011 and displayed until 30/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to information about pregnancy or lactation
Updated on 09/06/2011 and displayed until 18/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 14/09/2010 and displayed until 09/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 27/04/2010 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 12/05/2009 and displayed until 27/04/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/11/2008 and displayed until 12/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 07/11/2008 and displayed until 24/11/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/06/2008 and displayed until 07/11/2008
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change due to user-testing of patient information
Updated on 23/04/2008 and displayed until 09/06/2008
Reasons for adding or updating:
  • Change to Further Information section
Updated on 15/06/2007 and displayed until 23/04/2008
Reasons for adding or updating:
  • Change to drug interactions
Updated on 28/03/2007 and displayed until 15/06/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to MA holder contact details
Updated on 06/03/2007 and displayed until 28/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/05/2006 and displayed until 06/03/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 07/06/2005 and displayed until 04/05/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 14/03/2005 and displayed until 07/06/2005
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to information about driving or using machinery
  • Change to side-effects
Updated on 24/02/2005 and displayed until 14/03/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to warnings or special precautions for use
Updated on 04/01/2005 and displayed until 24/02/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/08/2004 and displayed until 04/01/2005
Reasons for adding or updating:
  • Change to storage instructions
  • Change to information about pregnancy or lactation
Updated on 22/07/2004 and displayed until 25/08/2004
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to storage instructions
  • Change to Further Information section
  • Change to date of revision
Updated on 10/03/2004 and displayed until 22/07/2004
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 15/08/2003 and displayed until 10/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 13/06/2003 and displayed until 15/08/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 02/05/2002 and displayed until 13/06/2003
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  tenofovir disoproxil fumarate